Clinical Trial Update: BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Botulinum Toxin Type A targeting peripheral neuropathic pain in carpal tunnel syndrome with neurogenic inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carpal Tunnel Syndrome
• Neurogenic Inflammation
• Neuropathic Pain

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Francesco Bono | Conditions: Carpal Tunnel Syndrome, Neurogenic Inflammation | Phase 2 | Status: UNKNOWN